First Time Loading...

ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 67.11 USD 0.89% Market Closed
Updated: May 3, 2024

ANI Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ANI Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Cash from Operating Activities
$119m
CAGR 3-Years
98%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$22.8B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.7B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$13B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$4.2B
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-3%

See Also

What is ANI Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
119m USD

Based on the financial report for Dec 31, 2023, ANI Pharmaceuticals Inc's Cash from Operating Activities amounts to 119m USD.

What is ANI Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
12%

The average annual Cash from Operating Activities growth rates for ANI Pharmaceuticals Inc have been 98% over the past three years , 12% over the past five years .